Always consult a veterinary physician or animal care specialist before using dipyrone injections.
Indications and Usage
Dipyrone is a very mild NSAID which has-spasmodic properties on the smooth muscle of the gastrointestinal tract which works for the treatment of colic (unexplained stomach pain). It is also used in controlling of diarrhea in cattle.
Dipyrone has anti-pyretic properties which help in reducing fever in foals and adult horses. It is also used in the pain management associated with urinary obstruction in horses and dogs.
Due to a risk of local reactions do not use the intramuscular route in horses. Do not use in animals with known hypersensitivity to the active ingredients. Do not use in horses suffering from paralytic ileus.
Administration and Dosage
Usual dosage is as follows: 20-50 mg/kg bw to horses, 20-40 mg/kg bw to cattle, 15-50 mg/kg bw to pigs by intravenous or intramuscular injection; and 1-5ml of dipyrone per kg body weight in dogs (intramuscularly, intravenously or subcutaneously). Dipyrone injections shouldn’t be administered if any hypersensitivity is discovered.
Completion of full treatment is always advisable with or without the presence of symptoms.
Refer to an animal care specialist for guidelines on dosage. Do not exceed what they advise, and complete the full treatment, as stopping early can result in a recurrence or worsening of the problem.
- Dipyrone is an NSAID which is given under supervision for animals with liver disease, kidney disease or GI problems. Discontinuation of therapy is recommended at the first sign of any adverse reaction such as anorexiaoral ulcers, depression, decreased plasma protein, increased creatinine, anemia or leukopenia;
- Dipyrone should be given slowly administered. Rapid administration may cause seizures;
- Dipyrone should be used with cautiousness in older or weak animals particularly those with cardiac disease;
- It should not be used in animals with a history of blood or bone marrow abnormalities.
Studies in laboratory animals (rabbit, rat) have not produced any evidence of a teratogenic effect. No information on use during pregnancy in the target species is available and therefore this product should not be used.
Avoid use of the product if you are sensitive to pyrazolones, or to aspirin. If accidental self-injection occurs, seek medical advice immediately.
Severity of side effects is increased with the administration of overdose; convulsions have been reported following acute overdose.
Interaction of atropine with chloropromazine which may lead to serious hypothermia. It also interacts with phenyl butazone or barbiturates leading to convulsions and seizures.